5 天之前 · Insulet Corporation is an innovative medical device company based in Acton, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through our revolutionary Omnipod Insulin Management System, we seek to expand the use of insulin pump therapy.

PDF, Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025, January 10, 2025, (opens in new window)

2022年10月17日 · Nov. 4, 2022- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH (r) Personal Diabetes Managers (PDMs) distributed globally. This action was taken voluntarily with the knowledge of the FDA and other regulatory agencies.

Find the latest Insulet Corporation (PODD) stock quote, history, news and other vital information to help you with your stock trading and investing.

Insulet Corp (PODD) 2023Q2電話會議重點摘要和逐字稿，了解分析師和法人關注焦點、產業狀況和公司競爭優勢。

免费获得根据Insulet (PODD)的最新财务报告而列出的重要财务比率表格，如市盈率（P/E）、每股收益（EPS）、投资回报率（ROI）等数据，可用于公司和股票基本面分析。

INSULET (PODD) のIR資料、FORM 10-K (2021Q4)のプレビューを表示しています。

6 天之前 · View the latest PODD 10K form and other Securities and Exchange Commission (SEC) filings for Insulet (NASDAQ:PODD) at MarketBeat.

Get the latest Insulet Corp (PODD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

2021年11月19日 · Insulet Corporation 是一家成立于 2000 年的美国创新医疗器械公司，其开发的全球首台无管路胰岛素泵Omnipod，因其革命性的无管路、贴敷式可穿戴设计，安全稳定并极具便捷性的使用体验，迅速获得全球糖尿病患者（T1D，T2D）的认可。 目前，全球约有1200万糖尿病患者使用着Omnipod胰岛素泵，Insulet 的市值超过200亿美元，拥有1900名员工。 John Brooks III是Insulet公司的联合创始人之一。 上世纪90年代中期，Brooks曾在辉瑞（Pfizer）领导部门 …